Research Article
Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial
Table 4
ANOVA predominant bacteria results,
values (log
10 transformed data).
| Predominant bacteria | Treatment | Time | Time by treatment |
| Bacteroides sp. | 0.686 | 0.198 | 0.992 | Clostridia sp. | 0.831 | 0.589 | 0.162 | Prevotella sp. | 0.279 | 0.800 | 0.279 | Fusobacteria sp. | 0.772 | 0.270 | 0.806 | Streptomyces sp. | 0.022 | 0.794 | 0.990 | Mycoplasma sp. | 0.097 | 0.719 | 0.106 | Lactobacillus sp. | 0.239 | 0.880 | 0.656 | Bifidobacteria sp. | 0.245 | 0.001 | 0.137 | Escherichia coli sp. | 0.235 | 0.051 | 0.516 | Total counts of predominant bacterial sp. | 0.252 | 0.877 | 0.458 |
|
|